The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Myovant Sciences's share price is $10.84.
Myovant Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2022 was $2.48. Hence, Myovant Sciences's PS Ratio for today is 4.36.
The historical rank and industry rank for Myovant Sciences's PS Ratio or its related term are showing as below:
MYOV'
s PS Ratio Range Over the Past 10 Years
Min: 3.49 Med: 30.81 Max: 71.19
Current: 4.29
During the past 7 years, Myovant Sciences's highest PS Ratio was 71.19. The lowest was 3.49. And the median was 30.81.
MYOV's PS Ratio is ranked better than 75.15% of 1010
companies
in the Biotechnology industry
Industry Median: 11.03
vs MYOV: 4.29
Myovant Sciences's Revenue per Sharefor the
three
months ended in Mar. 2022 was $0.61.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2022 was $2.48.
During the past 12 months, the average Revenue per Share Growth Rate of Myovant Sciences was 276.90% per year.
Back to Basics: PS Ratio
Myovant Sciences PS Ratio Historical Data
The historical data trend for Myovant Sciences's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Myovant Sciences Annual Data
Trend
Mar16
Mar17
Mar18
Mar19
Mar20
Mar21
Mar22
PS Ratio
-
-
-
31.23
5.36
Myovant Sciences Quarterly Data
Jun17
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
PS Ratio
31.23
31.06
14.23
7.26
5.36
Competitive Comparison
For the Biotechnology subindustry, Myovant Sciences's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Myovant Sciences PS Ratio Distribution
For the Biotechnology industry and Healthcare sector, Myovant Sciences's PS Ratio distribution charts can be found below:
* The bar in red indicates where Myovant Sciences's PS Ratio falls into.
Myovant Sciences PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Myovant Sciences's PS Ratio for today is calculated as
Myovant Sciences's Share Price of today is $10.84.
Myovant Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.48.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Myovant Sciences PS Ratio Related Terms
Thank you for viewing the detailed overview of Myovant Sciences's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Myovant Sciences Ltd is a healthcare company focused on redefining care for women and for men. The company's lead product candidate is relugolix, a once-daily, oral GnRH receptor antagonist. It has three late-stage clinical programs for relugolix in uterine fibroids, endometriosis, and prostate cancer. The company is also developing MVT-602, an oligopeptide kisspeptin-1 receptor agonist, that has completed a Phase 2a study for the treatment of female infertility as part of assisted reproduction.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.81(8.08%) Volume: 603,321 4:01PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:MYOV has been successfully added to your 
